TXMD icon

TherapeuticsMD
TXMD

Overview Fund Trends Analyst Outlook Journalist POV

43 hedge funds and large institutions have $13.8M invested in TherapeuticsMD in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

33% less call options, than puts

Call options by funds: $2.27M | Put options by funds: $3.4M

47% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 19

Holders
43
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.27M
Puts
$3.4M
Net Calls
Net Calls Change

Top Buyers

1
+$2.42M
2
+$551K
3
+$268K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$236K
5
Millennium Management
Millennium Management
New York
+$210K

Top Sellers

1
-$843K
2
-$814K
3
-$729K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$700K
5
Bank of America
Bank of America
North Carolina
-$537K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$2K
27
$2K
28
$2K
29
$1K
30
$1K
31
$133
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
1
2